Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Price, Quote, News and Overview

NASDAQ:MBOT - Nasdaq - US59503A2042 - Common Stock - Currency: USD

2.31  -0.24 (-9.41%)

Premarket: 2.24 -0.07 (-3.03%)

MBOT Quote, Performance and Key Statistics

MICROBOT MEDICAL INC

NASDAQ:MBOT (2/10/2025, 8:11:33 PM)

Premarket: 2.24 -0.07 (-3.03%)

2.31

-0.24 (-9.41%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.38
52 Week Low0.82
Market Cap39.11M
Shares16.93M
Float16.69M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-25 1992-03-25


MBOT short term performance overview.The bars show the price performance of MBOT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100

MBOT long term performance overview.The bars show the price performance of MBOT in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 60

The current stock price of MBOT is 2.31 USD. In the past month the price increased by 19.69%. In the past year, price increased by 79.07%.

MICROBOT MEDICAL INC / MBOT Daily stock chart

MBOT Latest News and Analysis

News Image
a day ago - Microbot Medical Inc.

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

BRAINTREE, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements...

News Image
7 days ago - Microbot Medical Inc.

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics

News Image
7 days ago - Microbot Medical Inc.

Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting

Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics...

MBOT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.12 227.75B
ISRG INTUITIVE SURGICAL INC 81.27 212.18B
BSX BOSTON SCIENTIFIC CORP 42.3 156.49B
SYK STRYKER CORP 32.21 149.67B
MDT MEDTRONIC PLC 17.3 116.48B
BDX BECTON DICKINSON AND CO 17.44 66.57B
EW EDWARDS LIFESCIENCES CORP 26.63 41.93B
GEHC GE HEALTHCARE TECHNOLOGY 20.73 39.98B
IDXX IDEXX LABORATORIES INC 41.33 38.07B
RMD RESMED INC 26.99 35.02B
DXCM DEXCOM INC 51.92 34.48B
PHG KONINKLIJKE PHILIPS NVR- NY 20.74 25.93B

About MBOT

Company Profile

MBOT logo image Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 22 full-time employees. The firm is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.

Company Info

MICROBOT MEDICAL INC

25 Recreation Park Dr Suite 108

Hingham MASSACHUSETTS 02043 US

CEO: Harel Gadot

Employees: 22

Company Website: http://www.microbotmedical.com/

Investor Relations: http://www.microbotmedical.com/investors/

Phone: 19089385561

MBOT FAQ

What is the stock price of MBOT?

The current stock price of MBOT is 2.31 USD.


What is the symbol for MICROBOT MEDICAL INC stock?

The exchange symbol of MICROBOT MEDICAL INC is MBOT and it is listed on the Nasdaq exchange.


On which exchange is MBOT stock listed?

MBOT stock is listed on the Nasdaq exchange.


Is MBOT a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MBOT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MBOT.


Does MBOT stock pay dividends?

MBOT does not pay a dividend.


What is the Price/Earnings (PE) ratio of MBOT?

MBOT does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.71).


What is the Short Interest ratio of MBOT stock?

The outstanding short interest for MBOT is 10.8% of its float.


MBOT Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to MBOT. When comparing the yearly performance of all stocks, MBOT is one of the better performing stocks in the market, outperforming 97.38% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MBOT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MBOT. The financial health of MBOT is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MBOT Financial Highlights

Over the last trailing twelve months MBOT reported a non-GAAP Earnings per Share(EPS) of -0.71. The EPS increased by 42.28% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -215.15%
ROE -294.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%4.76%
Sales Q2Q%N/A
EPS 1Y (TTM)42.28%
Revenue 1Y (TTM)N/A

MBOT Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to MBOT. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners8.01%
Ins Owners1.47%
Short Float %10.8%
Short Ratio0.51
Analysts
Analysts82.86
Price Target9.18 (297.4%)
EPS Next Y26.85%
Revenue Next YearN/A